Time in range is a tool for assessing the quality of glycemic control in diabetes

The presence of continuous glucose monitoring (CGM) systems has expanded diagnostic capabilities. The implementation of this technology into clinical practice allowed to determine the patterns and tendencies of excursions in glucose levels, to obtain reliable data concerning short-term glycemic cont...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	L. A. Suplotova, A. S. Sudnitsyna, N. V. Romanova, M. V. Shestakova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2021
Materias:	time in range diabetes continuous glucose monitoring Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/1525f3c7bcea4a2ca462b3e071834c4b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1525f3c7bcea4a2ca462b3e071834c4b
record_format	dspace
spelling	oai:doaj.org-article:1525f3c7bcea4a2ca462b3e071834c4b2021-11-14T09:00:23ZTime in range is a tool for assessing the quality of glycemic control in diabetes2072-03512072-037810.14341/DM12703https://doaj.org/article/1525f3c7bcea4a2ca462b3e071834c4b2021-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/12703https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378The presence of continuous glucose monitoring (CGM) systems has expanded diagnostic capabilities. The implementation of this technology into clinical practice allowed to determine the patterns and tendencies of excursions in glucose levels, to obtain reliable data concerning short-term glycemic control. Taking into consideration the large amount of obtained information using CGM systems, more than 30 different indicators characterizing glycemic variability were proposed. However, it is very difficult for a practitioner to interpret the data obtained due to the variety of indicators and the lack of their target values. The first step in the standardization of indices was the creation of the International Guidelines for CGM in 2017, where the Time in Range (TIR) (3,9–10,0 mmol/l, less often 3,9–7,8 mmol/l) was significant. To complement the agreed parameters and simplify the interpretation of obtained data using CGM, in 2019 the recommendations were prepared for the International Consensus on Time in Range, where TIR was validated as an additional component of the assessment of glycemic control along with HbA1c. In the literature review the issues of the association of TIR with the development of micro- and macrovascular complications in type 1 and 2 diabetes are considered. The relationship with other indicators of the glycemic control assessment was also analyzed and the dependence of insulin therapy on TIR was shown. TIR is a simple and convenient indicator, it has a proven link with micro- and macrovascular complications of diabetes and can be recommended as a new tool for assessing the glycemic control. The main disadvantage of TIR usage is the insufficient apply of CGM technology by the majority of patients with diabetes.L. A. SuplotovaA. S. SudnitsynaN. V. RomanovaM. V. ShestakovaEndocrinology Research Centrearticletime in rangediabetescontinuous glucose monitoringNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 24, Iss 3, Pp 282-290 (2021)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	time in range diabetes continuous glucose monitoring Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	time in range diabetes continuous glucose monitoring Nutritional diseases. Deficiency diseases RC620-627 L. A. Suplotova A. S. Sudnitsyna N. V. Romanova M. V. Shestakova Time in range is a tool for assessing the quality of glycemic control in diabetes
description	The presence of continuous glucose monitoring (CGM) systems has expanded diagnostic capabilities. The implementation of this technology into clinical practice allowed to determine the patterns and tendencies of excursions in glucose levels, to obtain reliable data concerning short-term glycemic control. Taking into consideration the large amount of obtained information using CGM systems, more than 30 different indicators characterizing glycemic variability were proposed. However, it is very difficult for a practitioner to interpret the data obtained due to the variety of indicators and the lack of their target values. The first step in the standardization of indices was the creation of the International Guidelines for CGM in 2017, where the Time in Range (TIR) (3,9–10,0 mmol/l, less often 3,9–7,8 mmol/l) was significant. To complement the agreed parameters and simplify the interpretation of obtained data using CGM, in 2019 the recommendations were prepared for the International Consensus on Time in Range, where TIR was validated as an additional component of the assessment of glycemic control along with HbA1c. In the literature review the issues of the association of TIR with the development of micro- and macrovascular complications in type 1 and 2 diabetes are considered. The relationship with other indicators of the glycemic control assessment was also analyzed and the dependence of insulin therapy on TIR was shown. TIR is a simple and convenient indicator, it has a proven link with micro- and macrovascular complications of diabetes and can be recommended as a new tool for assessing the glycemic control. The main disadvantage of TIR usage is the insufficient apply of CGM technology by the majority of patients with diabetes.
format	article
author	L. A. Suplotova A. S. Sudnitsyna N. V. Romanova M. V. Shestakova
author_facet	L. A. Suplotova A. S. Sudnitsyna N. V. Romanova M. V. Shestakova
author_sort	L. A. Suplotova
title	Time in range is a tool for assessing the quality of glycemic control in diabetes
title_short	Time in range is a tool for assessing the quality of glycemic control in diabetes
title_full	Time in range is a tool for assessing the quality of glycemic control in diabetes
title_fullStr	Time in range is a tool for assessing the quality of glycemic control in diabetes
title_full_unstemmed	Time in range is a tool for assessing the quality of glycemic control in diabetes
title_sort	time in range is a tool for assessing the quality of glycemic control in diabetes
publisher	Endocrinology Research Centre
publishDate	2021
url	https://doaj.org/article/1525f3c7bcea4a2ca462b3e071834c4b
work_keys_str_mv	AT lasuplotova timeinrangeisatoolforassessingthequalityofglycemiccontrolindiabetes AT assudnitsyna timeinrangeisatoolforassessingthequalityofglycemiccontrolindiabetes AT nvromanova timeinrangeisatoolforassessingthequalityofglycemiccontrolindiabetes AT mvshestakova timeinrangeisatoolforassessingthequalityofglycemiccontrolindiabetes
_version_	1718429451308498944

Time in range is a tool for assessing the quality of glycemic control in diabetes

Ejemplares similares